RXRG MODULATORS FOR THE TREATMENT OF CANCER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130324520A1
SERIAL NO

13985421

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides methods for treating cancer using modulators of retinoid X receptor gamma (RXRG). The ability of RXRG antagonists to disrupt the association of complexes comprising RXRG is demonstrated.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH1275 YORK AVENUE NEW YORK NY 10065

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Jhanwar, Suresh New York, US 1 1
Xu, Xiaoliang New York, US 9 16

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation